XBiotech

XBiotech is a biopharmaceutical company developing first-class antibody therapies. The company's leading candidate product inhibits chronic (sterile) inflammation—a condition associated with the progression of many severe and common diseases. XBiotech has multiple pioneering clinical trial programs across different medical fields, including dermatology, oncology, diabetes, cachexia, and cardiovascular diseases.